Home Page Contact Us Site Map
Home    Articles      Facts      Charity      Lawyers      Directory      Add a Link  &nbs
 
Alimta with cisplatin
The Food and Drug Administration (FDA) approved Alimta (pemetrexed disodium) for ...more
World Trade Center Asbestos
EPA collected wipe samples in a subset of the households that were...more
Diseases Caused By Asbestos Exposure
Pleural plaque is not cancer, and it does not cause cancer...more
Mesothelioma: A Killer Lurks in the Lungs

Mesothelioma & Asbestos News Page

Home Page

 

Greg Combet: Morality will prevail over profit

September 27, 2004

NOTHING in my working life has upset me as much as James Hardie's attempt to walk away from people who are suffering disease and death because of exposure to the company's asbestos products. It highlights a disconnection between commercial decisions and morality which is sickening.

The advice of investment analysts following the release of the damning report by the NSW Special Commission of Inquiry into James Hardie demonstrated just how fundamental this disconnection is. Record volumes of shares in the company were traded in response to analysts' advice urging investors to buy, buy, buy. The advice appears to be based on the belief that James Hardie has no legal obligation to pay compensation to victims of its deadly products.

These analysts must live in a cocoon.

The inquiry by David Jackson QC, handed down last week, found that the James Hardie restructure and move to the Netherlands three years ago has left the compensation fund for asbestos victims by the company at least $1.5 billion short. This means that thousands of Australians who are suffering or will suffer an asbestos-related disease, including those condemned to a painful death by mesothelioma, may be left without compensation.

Jackson also concluded that the company and its senior executives engaged in misleading and deceptive conduct for which criminal charges may be laid. Jackson also found that the NSW Supreme Court was misled. Corporate regulator the Australian Securities and Investments Commission immediately launched its own investigation.

On top of this, NSW Premier Bob Carr and other state leaders have dashed the company's last hope for a new government-run scheme that would limit compensation for victims. Carr has also commissioned the ACTU to conduct any negotiations with James Hardie.

The company's claim for a new statutory compensation scheme represents a belated and highly conditional recognition that it will have to pay up. But it also represents a demand for a stunning windfall reward for its disgusting corporate behaviour, at the expense of victims.

The company must not be rewarded in this way.

The Jackson report identifies many problems with the company's proposal for a statutory scheme, including the inherent inequity of a company-specific approach. Hardie victims could follow a different process and receive inferior compensation compared to asbestos victims of other companies such as CSR, which are meeting their obligations.

The Hardie scheme would also see victims lose in real terms as medical and other costs are expected to rise at a rate faster than the proposed level of Hardie compensation payouts.

In any event the James Hardie proposal is dead. Who could trust anything the company put forward?

The starting point for any resolution of the disgraceful mess involves an acceptance by James Hardie that it will compensate all victims of its products.

Beyond that it will be necessary to examine ways in which the existing asbestos compensation systems can be improved. There is scope for improving the efficiency and cost of the court-based processes.

Investment analysts must recognise that the long-term value of the company will only be realised if James Hardie meets its obligation to pay compensation. And that is because a full-scale industrial, legal and legislative assault on the company can be expected if no settlement is reached. And it won't stop at James Hardie.

There will also be a focus on the role and conduct of Hardie's legal and actuarial advisers in the under-funding of the Medical Research and Compensation Foundation.

The ACTU does not want to go down the path of further conflict if it is avoidable. The best outcome for the company and the victims lies in a settlement which delivers long-term profitability for James Hardie. Profitability will be the source of funding for compensation.

This is also the best outcome for investors. As Carr has warned, if James Hardie fails to settle, its share price will fall "until you won't notice it on any stock exchange in the world".

Investors and their analysts would do well to understand that morality will ultimately have a large bearing on the value of James Hardie. If I were an investment analyst I'd be saying the sooner the company pays up, the better.

 

Officials examine possible asbestos at Iqaluit dump site
WebPosted Sep 24 2004 07:17 PM CDT

IQALUIT - Officials in Iqaluit are investigating what they believe to be bags of asbestos at the metal dump.

Asbestos is a fiber used for insulation or to fireproof articles. Until the 1970s it was commonly used in building construction.

The fibres can easily be inhaled and can cause respiratory problems, or even lung cancer.

Bernie MacIssac of the department of Indian and northern affairs says the government of Nunavut is now looking into the case.

"A number of us went down actually and took a look at it, took some samples and as a precaution that it might be asbestos, we advised them that they should rope off the area," he says.

"We advised the government of Nunavut that what we had found and this morning we met with the government of Nunavut and they had basically taken the file and they're running with it."

MacIssac says his department will get involved if the substance is affecting nearby water bodies.

 

Back to News Page

 

Continue with:

Investor tools: Keeley fund looks for bargains By JAY LOOMIS THE JOURNAL NEWS (Original publication: September 26, 2004) EnPro Industries Inc. was a troubled stock unloved by others when it first caught John L. Keeley Jr.'s eye more than a year ago.

Case Hinges on Material Witness In a high-stakes lawsuit against Union Carbide, Exhibit A is an asbestos the company now says is safe By Lisa Girion, Times Staff Writer To hear Kelly-Moore's lawyer tell it, the Union Carbide salesmen had their mantra down: Don't worry, they'd say, don't worry.

With Angelos standing in way, eminent domain might not be imminent Originally published Sep 26, 2004 IF YOU BELIEVE everything that you read, it's time to start putting a few bucks aside each week to pay for your PSL at Citizens Don't Want To Bank This Ballpark in Washington.

With Angelos standing in way, eminent domain might not be imminent Originally published Sep 26, 2004 IF YOU BELIEVE everything that you read, it's time to start putting a few bucks aside each week to pay for your PSL at Citizens Don't Want To Bank This Ballpark in Washington.

University of Iowa settles Old Capitol lawsuit for $1.9 million IOWA CITY -- The University of Iowa has settled a lawsuit filed against the company blamed for starting a fire at the Old Capitol nearly three years ago.

A deadly shame 26sep04 LIKE the archetypal corporate villain in a B-grade movie, James Hardie Industries has been exposed as heartless as well as greedy - according to last week's Jackson inquiry.

Hardie head's hilltop hideout NICK PAPPS in Los Angeles 26sep04 THIS is the $6 million home where James Hardie boss Peter Macdonald has been hiding from the world.

Once Surrounded by Asbestos, Now Surrounded by Their Fears Some former Union Carbide mill workers worry that exposure to the mineral harmed them. The company cites a lack of evidence.

Payout for widow after husband's death BY DANIELLE NUTTALL September 25, 2004 06:14 A WIDOW has secured £126,000 damages after her husband died from a lung disease caused by exposure to asbestos at power stations.

 

 


General Information About Malignant Mesothelioma
Where can I find Asbestos?
Diagnosing Mesothelioma
Asbestos Information
Damages and Settlements
Medical Procedures
Drugs and Medications
Mesothelioma News
Articles       Facts       Charity       Lawyers       Directory       Add a Link       Clinical Trials       State Coverage